These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9753076)

  • 21. Futility of testing for factor V Leiden.
    Favaloro EJ; McDonald D
    Blood Transfus; 2012 Jul; 10(3):260-3. PubMed ID: 22889816
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is lifetime anticoagulation required in factor V Leiden mutation?].
    Pötzsch B
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1617. PubMed ID: 12884152
    [No Abstract]   [Full Text] [Related]  

  • 23. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
    Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
    J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of testing for factor V Leiden.
    Franchini M
    Blood Transfus; 2012 Jul; 10(3):257-9. PubMed ID: 22889815
    [No Abstract]   [Full Text] [Related]  

  • 26. Bilateral retinal vein occlusion associated with factor V Leiden mutation.
    Spagnolo BV; Nasrallah FP
    Retina; 1998; 18(4):377-8. PubMed ID: 9730185
    [No Abstract]   [Full Text] [Related]  

  • 27. Factor V Leiden: to test or not to test, that is the debate.
    Makris M
    Blood Transfus; 2012 Jul; 10(3):255-6. PubMed ID: 22889814
    [No Abstract]   [Full Text] [Related]  

  • 28. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
    Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
    Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers.
    Gaber Y; Siemens HJ; Schmeller W
    Br J Dermatol; 2001 Mar; 144(3):546-8. PubMed ID: 11260012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dangerous combination: Fabry disease and factor V Leiden.
    Niemann M; Weidemann F
    Intern Med J; 2012 Nov; 42(11):1270-1. PubMed ID: 23157526
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor V Leiden and venous thrombosis in a 4-yr-old girl with Behçet's syndrome.
    Ihle J; Kümmerle-Deschner J; Orlikowsky T; Albert E; Niethammer D; Dannecker GE
    Rheumatology (Oxford); 2000 Feb; 39(2):209-10. PubMed ID: 10725075
    [No Abstract]   [Full Text] [Related]  

  • 32. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutation of factor V Leiden and chronic leg edema with chronic venous insufficiency and recurrent thromboses].
    Chanda RA
    Praxis (Bern 1994); 1999 Sep; 88(36):1449-50. PubMed ID: 10500421
    [No Abstract]   [Full Text] [Related]  

  • 34. Factor V Leiden gene mutation in three South African families.
    Rubinstein R; Bowers D; Novitzky N; Louw I; Jacobs P
    S Afr Med J; 1999 Feb; 89(2):176. PubMed ID: 10191872
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor V Leiden in Mexico.
    Ruiz-Arguelles GJ
    Clin Appl Thromb Hemost; 2009; 15(3):366. PubMed ID: 19211579
    [No Abstract]   [Full Text] [Related]  

  • 36. Is factor V Leiden a risk factor for fetal loss?
    Dulícek P; Chrobák L; Kalousek I; Pesavová L; Pecka M; Stránský P
    Acta Medica (Hradec Kralove); 1999; 42(3):93-6. PubMed ID: 10677895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V Leiden with deep venous thrombosis.
    Gardner J
    Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.